15 July, 2026
[Re: https://www.hifa.org/dgroups-rss/spotlight-group-b-strep-55-should-there... ]
Neil, I think this would be an excellent topic for a future Spotlight. It could also address which risks and potential benefits should be included in informed consent as well as the patient-friendly terminology needed for it to be clear and understandable.
Best,
Marti
CHIFA profile: Marti Perhach is CEO/Cofounder of Group B Strep International, United States. Professional interests: Group B strep disease research and prevention, prenatal infection, One Health. www.groupbstrepinternational.org Email address: marti.perhach AT gbs-intl.org
Source link:
https://hifaforums.org/_/EjrouJgW